Amneal Pharmaceuticals, Inc.
AMRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Amneal Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 5,690,586 | $70.7M | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 4,266 | $53K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 52,543 | $653K | SEC filing |
| FARMERS & MERCHANTS INVESTMENTS INC | 2026-03-31 | 40 | $497 | SEC filing |
| Abacus Wealth Partners, LLC | 2026-03-31 | 23,418 | $291K | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 57,702 | $717K | SEC filing |
| Cornerstone Planning Group LLC | 2026-03-31 | 40 | $537 | SEC filing |
| Tidal Investments LLC | 2026-03-31 | 22,809 | $284K | SEC filing |
| Convergence Investment Partners, LLC | 2026-03-31 | 164,314 | $2.04M | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 81,051 | $1.01M | SEC filing |
| State of Tennessee, Department of Treasury | 2026-03-31 | 79,395 | $987K | SEC filing |
| Campbell & CO Investment Adviser LLC | 2026-03-31 | 60,620 | $754K | SEC filing |
| Corient Private Wealth LLC | 2026-03-31 | 11,130 | $138K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 32 | $398 | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 2026-03-31 | 19,816 | Not shown | SEC filing |
| Quantinno Capital Management LP | 2026-03-31 | 37,599 | $467K | SEC filing |
| Pictet Asset Management Holding SA | 2026-03-31 | 28,657 | $356K | SEC filing |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2026-03-31 | 20,175 | $251K | SEC filing |
| Parkman Healthcare Partners LLC | 2026-03-31 | 300,752 | $3.74M | SEC filing |
| Oliver Luxxe Assets LLC | 2026-03-31 | 156,285 | $1.94M | SEC filing |
- Each value is checked against Amneal Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Amneal Pharmaceuticals, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Amneal Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-08-20 · BOYER ANDREW S: Larger than 26 of the 27 other insider sales of Class A Common Stock on file. SEC filing
- 2025-08-15 · Konidaris Tasos: Larger than 25 of the 27 other insider sales of Class A Common Stock on file. SEC filing
- 2025-03-14 · Patel Tushar Bhikhubhai: Larger than all 27 other insider sales of Class A Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-11 | Autor Deborah M. · Director | Class A Common Stock | S — Open market or private sale | −34,819 | 12.94 | SEC filing |
| 2025-11-17 | Nark Ted C · Director | Class A Common Stock | S — Open market or private sale | −50,000 | 11.72 | SEC filing |
| 2025-11-12 | Shah Nikita · Executive Vice President | Class A Common Stock | S — Open market or private sale | −131,856 | 11.92 | SEC filing |
| 2025-08-27 | Kiely John · Director | Class A Common Stock | S — Open market or private sale | −32,000 | 9.23 | SEC filing |
| 2025-08-25 | Shah Nikita · Executive Vice President | Class A Common Stock | S — Open market or private sale | −6,340 | 9.50 | SEC filing |
| 2025-08-22 | Shah Nikita · Executive Vice President | Class A Common Stock | S — Open market or private sale | −114,492 | 9.66 | SEC filing |
| 2025-08-20 | BOYER ANDREW S · Executive Vice President | Class A Common Stock | S — Open market or private sale | −279,244 | 9.38 | SEC filing |
| 2025-08-15 | Konidaris Tasos · Executive Vice President & CFO | Class A Common Stock | S — Open market or private sale | −219,159 | 9.43 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-07 | BUCHI J KEVIN · Director | Class A Common Stock | M — Exercise or conversion of derivative security | +34,819 | SEC filing |
| 2026-05-07 | Yanai Shlomo · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −34,819 | SEC filing |
| 2026-05-07 | Nark Ted C · Director | Class A Common Stock | M — Exercise or conversion of derivative security | +34,819 | SEC filing |
| 2026-05-07 | Kiely John · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −34,819 | SEC filing |
| 2026-05-07 | Patel Gautam · Director | Class A Common Stock | M — Exercise or conversion of derivative security | +34,819 | SEC filing |
| 2026-05-07 | Nark Ted C · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −34,819 | SEC filing |
| 2026-05-07 | Patel Gautam · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −34,819 | SEC filing |
| 2026-05-07 | BUCHI J KEVIN · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −34,819 | SEC filing |
Showing 8 of 31 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.